Julie Veziant (@juveziant) 's Twitter Profile
Julie Veziant

@juveziant

MD,PhD, Digestive and oncological surgical département in Lille universitary hospital (Pr Piessen).

ID: 2474151420

calendar_today02-05-2014 15:10:20

10 Tweet

45 Followers

208 Following

Julie Veziant (@juveziant) 's Twitter Profile Photo

What a pleasure to share this teamwork on esophageal perforation piessen CHU de Lille Outcomes Associated with Esophageal Perforation Management: ... : Annals of Surgery journals.lww.com/annalsofsurger…

The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

New research - Liu et al - Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial thelancet.com/journals/langa… #GITwitter #OncTwitter OncoAlert

New research - Liu et al - Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

thelancet.com/journals/langa…

#GITwitter #OncTwitter <a href="/OncoAlert/">OncoAlert</a>
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Fluid collections 🐟 after distal pancreatectomy… real complications or just the way the pancreas heals ❤️‍🩹 ?! 💦 30 day prevalence 70% regardless of resection technique 🚨 POPF, PPAP and size > 5cm predictors of clinical relevance 🆓 link sciencedirect.com/science/articl…

Fluid collections 🐟 after distal pancreatectomy… real complications or just the way the pancreas heals ❤️‍🩹 ?!

💦 30 day prevalence 70% regardless of resection technique 

🚨 POPF, PPAP and size &gt; 5cm predictors of clinical relevance

🆓 link sciencedirect.com/science/articl…
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥PLENARY Session #ASCO24🔥 Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus 🔎 ESOPEC phase III trial, 438 patients 👉R0 180 vs 171 👉pCR 17 vs 10% 👉mOS 66 vs 37 mo 👉3yr OS: 57.4 vs 50.7% 🧐FLOT improves

🔥PLENARY Session #ASCO24🔥
Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus 
🔎 ESOPEC phase III trial, 438 patients
👉R0 180 vs 171
👉pCR 17 vs 10%
👉mOS 66 vs 37 mo
👉3yr OS: 57.4 vs 50.7%
🧐FLOT improves
ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

📣 Get updated recommendations in the ESMO #GastricCancer Living Guideline v1.3 from June, prepared by Florian Lordick and Elizabeth (Lizzy) Smyth. 🔗 ow.ly/opRP50StqWc

📣 Get updated recommendations in the ESMO #GastricCancer Living Guideline v1.3 from June, prepared by Florian Lordick and Elizabeth (Lizzy) Smyth.

🔗 ow.ly/opRP50StqWc
Steven D Wexner MD, PhD (@swexner) 's Twitter Profile Photo

Is preoperative smoking status a predictor of postoperative outcomes after esophagectomy for squamous cell carcinoma in a high-volume centre? surgjournal.com/article/S0039-… OPEN ACCESS SURGERY Journal from Julie Veziant William B Robb